Search
for
Sort by
Research 181–210 of 1000+
- Environmental Modulation of JAK3-Mediated Immune Dysregulation in Alopecia Areata
- The JAK/STAT signaling pathway: from bench to clinic
- <i>In vivo </i>CD44‐CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance
- Current Treatments for Alopecia Areata
- Under Development JAK Inhibitors for Dermatologic Diseases
- Answer
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Advances in the mechanism and new therapies of alopecia areata
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Regulation of Involucrin Gene Expression
- Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle
- JAK Inhibitors for Treatment of Alopecia Areata
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Alopecia areata – Current understanding and management
- Ruxolitinib found to cause eyelash growth: a case report
- Mechanisms of autophagy and their implications in dermatological disorders
- Baricitinib for the Treatment of Alopecia Areata
- Biologics in the management of childhood atopic dermatitis
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Inhibition of a signaling modality within the gp130 receptor enhances tissue regeneration and mitigates osteoarthritis
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology